The Effect of Marketing Variable on Effect of Active Drugs
NCT ID: NCT01493908
Last Updated: 2011-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
220 participants
INTERVENTIONAL
2012-01-31
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A Meta analysis checked 47 studies about placebo and showed great significance when a patient is treated with placebo pill, no active substance, just by activating conditioning and expectation mechanism in his body, thus providing to the healing process, and that is it's importance.
In recent years studies established a relationship between marketing variables (such as price, label) to the efficacy of a product. In addition- a unique research run in 2008 showed a significant relationship between the marketing strategies and the efficacy of medication; more specifically, patients in this research experienced less (controlled) pain when treated with placebo medication introduced to them as more expensive than patients treated with placebo medication that was introduced to them as much cheaper. All patients were treated with the exact same medication.
In the investigator's experiment the investigators design a laboratory experiment to determine if marketing factors could invoke the placebo effects described earlier. For the initial laboratory experiment, we decided to examine the difference in price, on the efficacy of an OTC analgesic through the mediation of low- voltage electrical pulses to the patient's wrist.
The investigators study hypothesis is that marketing variables such as price and brand name will affect the therapeutic efficacy of an analgesic, i.e. a medicine will have greater influence when the patient is aware of its price compared to one who is not.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High price
High price
Acetaminophen label as high price
Low price
Low price
Acetaminophen label as low price
Low price participants aware paying part
Low price participants aware paying part
Acetaminophen label as low price; participants aware they are paying part of the full price
No price
No price
acetaminophen. No price - price issue not introduced to participants.
Free of charge
Free of charge
Acetaminophen. participants aware the product is free of charge
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High price
Acetaminophen label as high price
Low price
Acetaminophen label as low price
Low price participants aware paying part
Acetaminophen label as low price; participants aware they are paying part of the full price
No price
acetaminophen. No price - price issue not introduced to participants.
Free of charge
Acetaminophen. participants aware the product is free of charge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Taking no pain medication at the time of the experiment.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hadassah Medical Organization
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amnon - Lahad, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Hebrew University, Jerusalem Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Family Medicine, Hebrew University, JerusaelmIsrael
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Amnon - Lahad, MD, MPH
Role: primary
Hadas Lemberg, PhD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1727-HMO-CTIL
Identifier Type: -
Identifier Source: org_study_id